碘对比剂使用与甲状腺功能障碍风险:美国退伍军人健康管理系统回顾性队列分析
该回顾性队列研究基于美国退伍军人健康管理数据库1998至2021年数据,纳入4,253,119名成人,分析碘对比剂暴露后甲状腺功能障碍风险。碘暴露与甲状腺功能障碍风险升高相关(OR=1.39,95%CI 1.37-1.41,p<0.001),男性风险高于女性,但绝对风险增加幅度临床意义较小。
要点
- 碘对比剂暴露与甲状腺功能障碍风险升高相关,OR=1.39(95%CI 1.37-1.41,p<0.001)。
- 男性风险高于女性:男性OR=1.42(95%CI 1.40-1.44),女性OR=1.16(95%CI 1.11-1.21),交互作用p<0.001。
- 碘暴露组甲状腺功能障碍发生率4.8%,无碘暴露组3.6%。
核心结论
- 在美国成人中,碘暴露与甲状腺功能障碍的绝对风险增加幅度临床意义较小,尤其在男性中。
- 作者认为碘对比剂使用后的甲状腺功能筛查应针对高风险个体。
研究设计与样本
- 基于美国退伍军人健康管理数据库1998至2021年的回顾性队列研究。
- 纳入年龄≥18岁且有血清促甲状腺激素(TSH)测量值的成人,共4,253,119名退伍军人(平均年龄63.5±14.3岁;92.9%男性;65.6%非西班牙裔白人),对应8,729,155对血清TSH测量值。
- 采用多变量logistic回归分析碘暴露后新发甲状腺功能障碍风险,调整年龄、性别、种族/族裔、基线血清TSH浓度及基线与随访TSH间隔时间。
主要发现
- 499,897对TSH测量值之间有碘暴露。
- 碘对比剂暴露组甲状腺功能障碍发生率为4.8%,无碘暴露组为3.6%。
- 碘暴露与甲状腺功能障碍风险升高相关(OR=1.39,95%CI 1.37-1.41,p<0.001),且在所有类型血清甲状腺功能障碍(显性或亚临床甲减/甲亢)中一致。
- 男性甲状腺功能障碍风险高于女性:男性OR=1.42(95%CI 1.40-1.44),女性OR=1.16(95%CI 1.11-1.21),交互作用p<0.001。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Iodine-induced thyroid dysfunction is a potential risk among susceptible individuals. Iodinated contrast media is a common source of an acute iodine load used in the health care setting and is frequently required for diagnostic computed tomography scans, coronary angiograms, and other radiologic studies. However, the epidemiologic risks of iodine-thyroid dysfunction have not been fully established in the United States. Methods: This population-based retrospective cohort study used the U.S. Veterans Health Administration database between 1998 and 2021 and included adults aged ≥18 years with a serum thyrotropin (TSH) measurement. Multivariable logistic regression was used to ascertain the risk of incident thyroid dysfunction (defined by repeated measurements of serum thyroid function) following iodine exposure, adjusting for age, sex, race/ethnicity, baseline serum TSH concentration, and duration between baseline and follow-up TSH concentration. Results: The cohort was composed of N = 4,253,119 veterans (mean ± SD = 63.5 ± 14.3 years; 92.9% men; 65.6% non-Hispanic Whites) with 8,729,155 corresponding pairs of serum TSH measurements, from which there were 499,897 TSH pairs with intervening iodine exposure. Thyroid dysfunction occurred in 4.8% of those pairs who had received iodine contrast and 3.6% of those without iodine exposure. Iodinated exposure was associated with an increased risk of thyroid dysfunction (odds ratio [OR] = 1.39, 95% confidence intervals [CI] = 1.37-1.41, p < 0.001) and consistent for all types of serum thyroid dysfunction (overt or subclinical hypo-/hyperthyroidism). Men were at higher risk for the development of thyroid dysfunction than women (men: OR = 1.42, 95% CI = 1.40-1.44; women: OR = 1.16, 95% CI = 1.11-1.21; p-for-interaction <0.001). Conclusions: In this largest analysis of U.S. adults to date, iodine exposure was associated with only clinically small absolute increased risks of thyroid dysfunction, particularly in men. These findings suggest that screening of thyroid function following iodinated contrast administration should be targeted to high-risk individuals.
引用
- Inoue K, Guo R, Lee ML, et al. Iodinated Contrast Administration and Risks of Thyroid Dysfunction: A Retrospective Cohort Analysis of the U.S. Veterans Health Administration System. Thyroid. 2023. PMID: 36173108. doi:10.1089/thy.2022.0393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。